Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martine J Hollestelle

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|September 3, 2019
International external quality assessment for measurements of direct oral anticoagulants: results and recommendationsMartine J Hollestelle, Piet Meijer
Seminars in Thrombosis and Hemostasis|October 12, 2022
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International SurveyMartine J Hollestelle, Joost C M Meijers, Piet Meijer
Seminars in Thrombosis and Hemostasis|September 2, 2022
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International SurveyMartine J Hollestelle, Joost C M Meijers, Piet Meijer
Journal of Thrombosis and Haemostasis : JTH|June 24, 2020
Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagentsMotalib Smahi, Neila De Pooter, Martine J Hollestelle, et al.
Clinical Chemistry and Laboratory Medicine|May 23, 2020
Quality performance for indirect Xa inhibitor monitoring in patients using international external quality dataMartine J Hollestelle, Felix J M van der Meer, Piet Meijer
Seminars in Thrombosis and Hemostasis|October 17, 2024
D-dimer-An International Assessment of the Quality of Laboratory Testing: Implications for D-dimer Use in the Real WorldCarolyne Elbaz, Martine J Hollestelle, Piet Meijer, et al.
Endocrine-Related Cancer|March 4, 2008
Characterization of gastrin-cholecystokinin 2 receptor interaction in relation to c-fos inductionMartine J Hollestelle, Peter Timmerman, Rob H Meloen, et al.
Thrombosis Research|September 15, 2015
von Willebrand activation factor as a marker of mortality, cardiovascular events, and bleeding complications in patients treated with oral anticoagulantsMarcus Lind, Lars Johansson, Torbjörn K Nilsson, et al.
Seminars in Thrombosis and Hemostasis|September 19, 2022
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last DecadeYonah C Ziemba, Jameel Abdulrehman, Martine J Hollestelle, et al.
Clinical Chemistry and Laboratory Medicine|March 7, 2019
Determination of sigma score based on biological variation for haemostasis assays: fit-for-purpose for daily practice?Martine J Hollestelle, Janneke Ruinemans-Koerts, René N Idema, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|September 3, 2019
International external quality assessment for measurements of direct oral anticoagulants: results and recommendationsMartine J Hollestelle, Piet Meijer
Seminars in Thrombosis and Hemostasis|October 12, 2022
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International SurveyMartine J Hollestelle, Joost C M Meijers, Piet Meijer
Seminars in Thrombosis and Hemostasis|September 2, 2022
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International SurveyMartine J Hollestelle, Joost C M Meijers, Piet Meijer
Journal of Thrombosis and Haemostasis : JTH|June 24, 2020
Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagentsMotalib Smahi, Neila De Pooter, Martine J Hollestelle, et al.
Clinical Chemistry and Laboratory Medicine|May 23, 2020
Quality performance for indirect Xa inhibitor monitoring in patients using international external quality dataMartine J Hollestelle, Felix J M van der Meer, Piet Meijer
Seminars in Thrombosis and Hemostasis|October 17, 2024
D-dimer-An International Assessment of the Quality of Laboratory Testing: Implications for D-dimer Use in the Real WorldCarolyne Elbaz, Martine J Hollestelle, Piet Meijer, et al.
Endocrine-Related Cancer|March 4, 2008
Characterization of gastrin-cholecystokinin 2 receptor interaction in relation to c-fos inductionMartine J Hollestelle, Peter Timmerman, Rob H Meloen, et al.
Thrombosis Research|September 15, 2015
von Willebrand activation factor as a marker of mortality, cardiovascular events, and bleeding complications in patients treated with oral anticoagulantsMarcus Lind, Lars Johansson, Torbjörn K Nilsson, et al.
Seminars in Thrombosis and Hemostasis|September 19, 2022
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last DecadeYonah C Ziemba, Jameel Abdulrehman, Martine J Hollestelle, et al.
Clinical Chemistry and Laboratory Medicine|March 7, 2019
Determination of sigma score based on biological variation for haemostasis assays: fit-for-purpose for daily practice?Martine J Hollestelle, Janneke Ruinemans-Koerts, René N Idema, et al.
Pageof 3